Sera Prognostics, Inc.
Sera Prognostics, Inc. (SERA) Company Profile & Overview
Explore Sera Prognostics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Sera Prognostics, Inc. (SERA) Company Profile & Overview
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.